First-in-human phase 1 study of CC-94676, a first-in-class androgen receptor (AR) ligand-directed degrader (LDD), in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Rathkopf, D. E.; Patel, M. R.; Choudhury, A. D.; Rasco, D. W.; Lakhani, N. J.; Hawley, J. E.; Aparicio, A.; Narayan, V.; Srinivas, S.; Runcie, K.; Emamekhoo, H.; Reichert, Z. R.; Carducci, M. A.; Wells, A. L.; Liu, C.; Kandimalla, R.; Wu, J.; Nguyen, M. H.; Pourdehnad, M.; Armstrong, A. J. |
| Abstract Title: | First-in-human phase 1 study of CC-94676, a first-in-class androgen receptor (AR) ligand-directed degrader (LDD), in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) |
| Meeting Title: | 2024 ASCO Genitourinary Cancers Symposium |
| Keywords: | 261-566-148; 261-492-199-2823-10594-7548-5180; 613-545-552; 283-2494-5577-2829-12292; 261-137-7318-7319; 3282-206-4957-3975-3408-6824; 261-436; 38092-18135 |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2024 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-02-01 |
| Language: | English |
| ACCESSION: | WOS:001266676900560 |
| DOI: | 10.1200/JCO.2024.42.4_suppl.134 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 134 -- Source: Wos |
